Iht Wealth Management, LLC Sorrento Therapeutics, Inc. Transaction History

Iht Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.0 - $4.9 $250 - $612	-125 Reduced 0.71%	17,368 $40,000
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $11,485 - $17,034	-1,550 Reduced 8.14%	17,493 $133,000
Q1 2021 May 18, 2021	SELL	$7.03 - $16.51 $99,910 - $234,640	-14,212 Reduced 42.74%	19,043 $157,000
Q4 2020 Feb 17, 2021	BUY	$5.76 - $11.95 $9,043 - $18,761	1,570 Added 4.96%	33,255 $227,000
Q3 2020 Nov 19, 2020	BUY	$6.17 - $18.82 $308 - $941	50 Added 0.16%	31,685 $353,000
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $54,728 - $213,852	31,635 New	31,635 $199,000
Q2 2018 Aug 13, 2018	SELL	$4.75 - $8.0 $2,009 - $3,384	-423 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.5 - $9.95 $1,903 - $4,208	423 New	423 $2,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.